Plasma growth differentiation factor - 8 / Myostatin level as prognostic biomarker of patients with ischemic stroke and acute revascularization therapy. PARADISE study.
Fiche publication
Date publication
mars 2023
Journal
Journal of the neurological sciences
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGELY Catherine
Tous les auteurs :
Jakubina P, Meloux A, Duloquin G, Aho S, Vergely C, Béjot Y
Lien Pubmed
Résumé
Identifying biological markers of ischemic stroke (IS) is an important research approach to develop innovative therapeutic strategies. This study aimed to assess the association between plasma Growth Differentiation Factor-8 (GDF-8)/Myostatin levels and outcome of IS patients.
Mots clés
GDF-8, Ischemic stroke, Myostatin, Neuronal plasticity, Prognosis
Référence
J Neurol Sci. 2023 03 16;448:120611